Monday, October 18, 2021
News

Glenmark gets USFDA approval for Clindamycin Phosphate Foam 1%

   SocialTwist Tell-a-Friend    Print this Page   COMMENT

Chennai | Tuesday, 2021 7:45:06 PM IST
Pharma major Glenmark Pharmaceuticals Ltd on Tuesday said it has received final approval by the United States Food & Drug Administration (USFDA) for Clindamycin Phosphate Foam, 1 per cent, the generic version of Evoclin Foam, 1 per cent, of Mylan Pharmaceuticals Inc.

According to IQVIA sales data for the 12 month period ending July 2021, the Evoclin Foam, 1 per cent, market achieved annual sales of approximately $12.0 million.

Glenmark's current portfolio consists of 173 products authorized for distribution in the US marketplace and 47 ANDA's (Abbreviated New Drug Application) pending approval with the US FDA.

In addition to these internal filings, Glenmark continues to identify and explore external development partnerships to supplement and accelerate the growth of its existing pipeline and portfolio, the company said.

--IANS vj/in

( 139 Words)

2021-09-21-13:44:11 (IANS)

 
  LATEST COMMENTS ()
POST YOUR COMMENT
Comments Not Available
 
POST YOUR COMMENT
 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
 
MORE HEALTH NEWS
UK records more than 40,000 Covid cases ...
India logs 13,596 new Covid cases, lowes...
Mumbai records no Covid death, for first...
K'taka lifts curbs at MM Hills pilgrimag...
Turkey reports 24,114 daily Covid-19 cas...
Aus secures access to 2 more Covid treat...
More...
 
INDIA WORLD ASIA
Hope security measures taken for migrant...
Govt procures paddy worth Rs 11,099 cror...
PM Modi to inaugurate UP's Kushinagar In...
Days after NIA raids on ISIS propaganda ...
O.P. Jindal Global University launches 1...
Kerala floods: Blame game begins as deat...
More...    
 
 Top Stories
Indian martial art Kalaripayattu ha... 
Gulf Islamic Investment to open off... 
This T20 World Cup could belong to ... 
National Liberation Front of Tripur... 
Protests against price hike held in... 
T20 WC: Under ICC's international c... 
First children-friendly COVID-19 va... 
Former US State Secretary Colin Pow...